Key Details
Price
$1.99Annual ROE
-173.34%Beta
1.09Events Calendar
Next earnings date:
Mar 27, 2025Recent quarterly earnings:
Nov 14, 2024Recent annual earnings:
Mar 27, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Jun 30, 2023Analyst ratings
Recent major analysts updates
Feb 12, 25 HC Wainwright & Co.
NeutralNov 8, 24 Jefferies
BuyOct 14, 24 HC Wainwright & Co.
BuyAug 16, 24 HC Wainwright & Co.
BuyMay 21, 24 HC Wainwright & Co.
BuyMar 7, 24 HC Wainwright & Co.
BuyMar 5, 24 HC Wainwright & Co.
BuyAug 15, 23 HC Wainwright & Co.
BuyJun 30, 23 HC Wainwright & Co.
BuyJun 22, 23 HC Wainwright & Co.
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Inhibikase Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Inhibikase Therapeutics?
- Does Inhibikase Therapeutics pay dividends?
- What sector is Inhibikase Therapeutics in?
- What industry is Inhibikase Therapeutics in?
- What country is Inhibikase Therapeutics based in?
- When did Inhibikase Therapeutics go public?
- Is Inhibikase Therapeutics in the S&P 500?
- Is Inhibikase Therapeutics in the NASDAQ 100?
- Is Inhibikase Therapeutics in the Dow Jones?
- When was Inhibikase Therapeutics's last earnings report?
- When does Inhibikase Therapeutics report earnings?
- Should I buy Inhibikase Therapeutics stock now?
What is the ticker symbol for Inhibikase Therapeutics?
The ticker symbol for Inhibikase Therapeutics is NASDAQ:IKT
Does Inhibikase Therapeutics pay dividends?
No, Inhibikase Therapeutics does not pay dividends
What sector is Inhibikase Therapeutics in?
Inhibikase Therapeutics is in the Healthcare sector
What industry is Inhibikase Therapeutics in?
Inhibikase Therapeutics is in the Biotechnology industry
What country is Inhibikase Therapeutics based in?
Inhibikase Therapeutics is headquartered in United States
When did Inhibikase Therapeutics go public?
Inhibikase Therapeutics's initial public offering (IPO) was on December 23, 2020
Is Inhibikase Therapeutics in the S&P 500?
No, Inhibikase Therapeutics is not included in the S&P 500 index
Is Inhibikase Therapeutics in the NASDAQ 100?
No, Inhibikase Therapeutics is not included in the NASDAQ 100 index
Is Inhibikase Therapeutics in the Dow Jones?
No, Inhibikase Therapeutics is not included in the Dow Jones index
When was Inhibikase Therapeutics's last earnings report?
Inhibikase Therapeutics's most recent earnings report was on Nov 14, 2024
When does Inhibikase Therapeutics report earnings?
The next expected earnings date for Inhibikase Therapeutics is Mar 27, 2025
Should I buy Inhibikase Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions